208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug...

18
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208686Orig1s000 CHEMISTRY REVIEW(S)

Transcript of 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug...

Page 1: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

CENTER FOR DRUG EVALUATION AND RESEARCH

APPLICATION NUMBER:

208686Orig1s000

CHEMISTRY REVIEW(S)

Page 2: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 3: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 4: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 5: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 6: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 7: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 8: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 9: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 10: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 11: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 12: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 13: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 14: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 15: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 16: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 17: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development
Page 18: 208686Orig1s000 - Food and Drug Administration Summary I. Recommendations A ... C. Summary of Drug Product Intended Use Pro rieta Name of the Dr Product ... Pharmaceutical Development

Your Monthly Prescription Drug Summary - … Monthly Prescription Drug Summary . ... (TTY Spanish) Customer Services ... STAGE 1 : Yearly Deductible

Your Monthly Prescription Drug Summary - … Monthly Prescription Drug Summary . ... (TTY Spanish) Customer Services ... STAGE 1 : Yearly Deductible

World Drug Report 2010 Summary

World Drug Report 2010 Summary

CENTER FOR DRUG EVALUATION AND … for drug evaluation and research . application number: 125553orig1s000. summary review

CENTER FOR DRUG EVALUATION AND … for drug evaluation and research . application number: 125553orig1s000. summary review

The Multi-Site Adult Drug Court Evaluation: Executive Summary

The Multi-Site Adult Drug Court Evaluation: Executive Summary

Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual … · 2015. 7. 1.  · Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual Report.

Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual … · 2015. 7. 1.  · Comparison/Summary Report FFY 2012 Medicaid Drug Utilization Review Annual Report.

Ontario Drug Benefit Formulary/Comparative Drug Index · 1 . Ontario Drug Benefit . Formulary/Comparative Drug Index . Edition 43 . Summary of Changes – January 2020 . Effective

Ontario Drug Benefit Formulary/Comparative Drug Index · 1 . Ontario Drug Benefit . Formulary/Comparative Drug Index . Edition 43 . Summary of Changes – January 2020 . Effective

Medicaid Drug Utilization Review State Comparison/Summary ...

Medicaid Drug Utilization Review State Comparison/Summary ...

Drug Overdose Summary - Mendocino County, CAassets.thehcn.net/content/sites/mendocino/AOD... · 2015. 3. 2. · Drug Overdose Summary Tables Years Male 2002-2004 2003-2005 2004-2006

Drug Overdose Summary - Mendocino County, CAassets.thehcn.net/content/sites/mendocino/AOD... · 2015. 3. 2. · Drug Overdose Summary Tables Years Male 2002-2004 2003-2005 2004-2006

Drug Policy Modelling Project · 2012-02-28 · DRUG POLICY MODELLING PROGRAM . MONOGRAPH 16. A SUMMARY OF DIVERSION PROGRAMS . FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA .

Drug Policy Modelling Project · 2012-02-28 · DRUG POLICY MODELLING PROGRAM . MONOGRAPH 16. A SUMMARY OF DIVERSION PROGRAMS . FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA .

NCCP Regimen Information Summary - by Drug Last updated ...

NCCP Regimen Information Summary - by Drug Last updated ...

Global report on antimalarial druG efficacy and druG ... · 3 Global report on antimalarial drug efficacy and drug resistance: 2000–2010 Executive summary BACkground Plasmodium

Global report on antimalarial druG efficacy and druG ... · 3 Global report on antimalarial drug efficacy and drug resistance: 2000–2010 Executive summary BACkground Plasmodium

Alcohol (Canadian Drug Summary) - ccsa.ca

Alcohol (Canadian Drug Summary) - ccsa.ca

FY 2014 BUDGET AND PERFORMANCE SUMMARY - … · NATIONAL DRUG CONTROL STRATEGY: FY 2014 Budget and Performance Summary 7 Executive Summary In support of the 2013 National Drug Control

FY 2014 BUDGET AND PERFORMANCE SUMMARY - … · NATIONAL DRUG CONTROL STRATEGY: FY 2014 Budget and Performance Summary 7 Executive Summary In support of the 2013 National Drug Control

WHAT Outline WHY 1. What are Adverse Drug Reactions (ADRs ...€¦ · What are Adverse Drug Reactions (ADRs)? 2. ... Drug Allergy –case summary ... Pictures-from HSA, Adverse Drug

WHAT Outline WHY 1. What are Adverse Drug Reactions (ADRs ...€¦ · What are Adverse Drug Reactions (ADRs)? 2. ... Drug Allergy –case summary ... Pictures-from HSA, Adverse Drug

Summary Report on EU Drug Precursors Seizures 2008

Summary Report on EU Drug Precursors Seizures 2008

Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey€¦ · Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey California Environmental Protection

Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey€¦ · Summary of the 2002-2003 Clandestine Drug Laboratory Remediation Survey California Environmental Protection

Methamphetamine (Canadian Drug Summary)...Canadian Drug Summary: Methamphetamine Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage

Methamphetamine (Canadian Drug Summary)...Canadian Drug Summary: Methamphetamine Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage

RICK SCOTT GOVERNOR SUMMARY OF DRUG LIMITATIONS

RICK SCOTT GOVERNOR SUMMARY OF DRUG LIMITATIONS

Mechanisms of drug hypersensitivity KDIGOkdigo.org/.../02/12.-Bircher_Mechanisms-of-Drug-Hypersensitivity-.pdf · Mechanisms of drug hypersensitivity ... Summary iron hypersensitivity

Mechanisms of drug hypersensitivity KDIGOkdigo.org/.../02/12.-Bircher_Mechanisms-of-Drug-Hypersensitivity-.pdf · Mechanisms of drug hypersensitivity ... Summary iron hypersensitivity

KINDReD Final Report: Publishable summary Executive summary · KINDReD Final Report: Publishable summary Executive summary The Kinetoplastid Drug Development (KINDReD) consortium

KINDReD Final Report: Publishable summary Executive summary · KINDReD Final Report: Publishable summary Executive summary The Kinetoplastid Drug Development (KINDReD) consortium